2004
DOI: 10.1080/14622200410001669141
|View full text |Cite
|
Sign up to set email alerts
|

Measurements for active cigarette smoke exposure in prevalence and cessation studies: Why simply asking pregnant women isn't enough

Abstract: Tobacco smoke exposure during and after pregnancy may cause maternal, fetal, and infant morbidity and mortality. The purpose of this review is to (a). describe existing methods of measuring active tobacco exposure among pregnant women and (b). illustrate the usefulness of these measures in validating self-reported smoking status among these women. Medline, PsycINFO, and Academic Search Elite were used to identify measures of cigarette smoking exposure, prevalence reports, cessation and validity studies, and re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
91
0
8

Year Published

2007
2007
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 116 publications
(106 citation statements)
references
References 54 publications
5
91
0
8
Order By: Relevance
“…In England,15% of Bangladeshi female immigrants underreport their personal tobacco use, while in Iran, where female self-reported smoking prevalence is 1.3%, serum cotinine-verified prevalence is 6.7% (SarrafZadegan et al, 2004;Roth, 2009). Female under-reporting has also been documented in Tunisia and Canada and so on (Russell et al, 2004;Fakhfakh et al, 2011;Wong et al, 2012).…”
Section: Discussionmentioning
confidence: 99%
“…In England,15% of Bangladeshi female immigrants underreport their personal tobacco use, while in Iran, where female self-reported smoking prevalence is 1.3%, serum cotinine-verified prevalence is 6.7% (SarrafZadegan et al, 2004;Roth, 2009). Female under-reporting has also been documented in Tunisia and Canada and so on (Russell et al, 2004;Fakhfakh et al, 2011;Wong et al, 2012).…”
Section: Discussionmentioning
confidence: 99%
“…Validated biochemical measures of tobacco exposure over gestation can be measured in maternal saliva, urine, hair, nails, and plasma or serum nicotine/cotinine (Benowitz, Hukkanen, & Jacob, 2009). Previous research has shown salivary cotinine to be the most sensitive test of MSDP (Russell, Crawford, & Woodby, 2004). Of note, metabolism of nicotine/cotinine is increased in pregnancy due to increased circulating sex hormones (Benowitz et al, 2009).…”
Section: Msdp Measurementmentioning
confidence: 99%
“…However, it has been shown that variation in smoking habits, such as the length or frequency of puffs (known as smoking topography), can lead to different levels of exposure even when smoking the same amount of cigarettes (7). Furthermore, in certain situations, such as during pregnancy or among adolescents, smokers may deliberately or unconsciously underreport smoking status or the number of cigarettes smoked (3,(8)(9)(10)(11) because of growing awareness of health risks and social rejection of smoking. Another important source of variability of exposure to tobacco smoke that cannot be quantified by self-report of smoking are differences in metabolism of tobacco, which varies by race, gender, and age, and leads to different levels of internal exposure from smoking a similar number of cigarettes (12).…”
Section: Introductionmentioning
confidence: 99%
“…The lack of accurate and reliable methods for measurement of long-term exposure to tobacco smoke leads to measurement error, which results in an underestimation of the health risks (2). Questionnaires are still the most common method of measuring exposure to tobacco smoke, although biomarkers and other environmental and personal monitors are being frequently used (3)(4)(5)(6). Nevertheless, there is no ''gold standard'' method for measurement of the overall exposure to tobacco smoke.…”
Section: Introductionmentioning
confidence: 99%